Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2008
02/20/2008EP1888532A1 Heteroaroyl-substituted serine amides
02/20/2008EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists
02/20/2008EP1888528A2 Phosphodiesterase 4 inhibitors
02/20/2008EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1888058A2 Inhibitors of soluble adenylate cyclase
02/20/2008EP1740569B1 Imidazole derivatives used as tafia inhibitors
02/20/2008EP1675832B1 Heterocyclyl compounds
02/20/2008EP1558247B1 Benzimidazole derivatives
02/20/2008EP1448561B1 Beta 3 adrenergic agonists
02/20/2008EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer
02/20/2008CN101128458A Tricyclic delta-opioid modulators
02/20/2008CN101128432A Tetrahydroisoquinoline compounds for treatment of cns disorders
02/20/2008CN101126021A Bi-vinyl anthracenes luminescent compounds
02/20/2008CN101125850A Andrographolide derivatives and application of the same in pharmacy
02/20/2008CN100369899C Substituted indazoles with anti-cancer activity
02/20/2008CN100369898C Nicotinamide derivates useful as p38 inhibitors
02/19/2008US7332631 Fc receptor modulating compounds and compositions
02/19/2008US7332616 Polymerizable compound, polymer, positive-resist composition, and patterning process using the same
02/19/2008US7332521 Substituted indoles
02/19/2008US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding
02/19/2008US7332511 Vanilloid receptor ligands and their use in treatments
02/19/2008US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths
02/19/2008US7332503 Aporphine esters and their use in therapy
02/19/2008US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor
02/19/2008US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent
02/19/2008US7332489 Methods and compositions of novel triazine compounds
02/19/2008US7332488 Methods and compositions of novel triazine compounds
02/19/2008US7332487 Nitrogen-containing 5-membered ring compound
02/19/2008US7332484 2,4-pyrimidinediamine compounds and their uses
02/19/2008US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease
02/19/2008US7332481 Thrombopoietin mimetics
02/19/2008US7332260 Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them
02/19/2008CA2481723C 5ht2c receptor modulators
02/19/2008CA2226582C Non-allosteric gabaa agonists for treating sleep disorders
02/19/2008CA2207100C Pyrimidine derivatives
02/14/2008WO2008018639A2 Glycine transporter inhibitor
02/14/2008WO2008018306A1 Quinazoline derivative
02/14/2008WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
02/14/2008WO2008017164A1 Thiophenecarboxamide derivatives as ep4 receptor ligands
02/14/2008WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases
02/14/2008WO2007143456A3 Benzimidazol substituted thiophene derivatives with activity on plk
02/14/2008WO2007139955A8 Triazole compounds that modulate hsp90 activity
02/14/2008WO2007136302A3 Active substances, pharmaceutical composition and a method for the production and use thereof
02/14/2008US20080039622 2,4-pyrimidinediamine compounds and their uses
02/14/2008US20080039505 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension
02/14/2008US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache
02/14/2008US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease
02/14/2008US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
02/14/2008US20080039446 Substituted isoindoles and their use
02/14/2008US20080039442 Compounds With Kv4 Ion Channel Activity
02/14/2008US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
02/14/2008US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin
02/14/2008CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
02/14/2008CA2660133A1 Thiophenecarboxamide derivatives as ep4 receptor ligands
02/14/2008CA2659967A1 Quinazoline derivatives
02/13/2008EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions
02/13/2008EP1886994A1 Cyclic amine compounds as CCR5 antagonists
02/13/2008EP1885712A1 New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.
02/13/2008EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators
02/13/2008EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
02/13/2008EP1335908B1 Peroxisome proliferator activated receptor alpha agonists
02/13/2008CN101124208A Novel heteroaryl acetamide
02/13/2008CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor
02/12/2008US7329766 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives
02/12/2008US7329765 Benzothiophene compounds having antiinfective activity
02/12/2008US7329764 Substitute benzothiophene compounds
02/12/2008US7329685 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases
02/12/2008US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound
02/12/2008US7329680 Heterocycle substituted carboxylic acids
02/12/2008US7329675 Substituted azabicyclic compounds
02/12/2008US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors
02/12/2008US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent
02/12/2008CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them
02/12/2008CA2260863C Treatment of psychotic disorders
02/12/2008CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
02/07/2008WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/07/2008WO2008016107A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
02/07/2008WO2008016095A1 PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
02/07/2008WO2008015189A2 Fungicidal n-cycloalkyl-carboxamide derivatives
02/07/2008WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008WO2007136300A3 Substituted indoles and a method for the production and use thereof
02/07/2008WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors
02/07/2008WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/07/2008WO2006105304A8 Phenyl and pyridyl lta4h modulators
02/07/2008US20080033179 Exhibit performance properties suited to high-speed optical recording applications; industrial scale; cyanine dyes; indole dyes; cationic dyes; low heat decomposition temperatures
02/07/2008US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders
02/07/2008US20080033023 Therapeutic compounds
02/07/2008US20080032993 Substituted heterocyclic compounds
02/07/2008US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them
02/07/2008US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
02/07/2008DE10361713B4 Verwendung von Charge-Transfer-Komplexen aus einem Elektronendonor und einem Elektronenakzeptor als Basis für resistive Speicher und Speicherzelle enthaltend diese Komplexe Use of charge-transfer complexes made of an electron donor and an electron acceptor as the basis for memory and resistive memory cell comprising these complexes
02/07/2008CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
02/07/2008CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/06/2008CN101119985A N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application
02/06/2008CN101119970A Azadecalin glucocorticoid receptor modulators
02/06/2008CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
02/06/2008CN100366619C Method for preparing Oltipraz